These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33878399)

  • 81. Recombinant P4 bacteriophages propagate as viable lytic phages or as autonomous plasmids in Klebsiella pneumoniae.
    Ow DW; Ausubel FM
    Mol Gen Genet; 1980; 180(1):165-75. PubMed ID: 6255293
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
    Timofte D; Dan M; Maciuca IE; Ciucu L; Dabija ER; Guguianu E; Panzaru CV
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Colistin Resistance in KPC-2- and SHV-5-Producing Klebsiella pneumoniae Clinical Isolates in Bulgaria.
    Savov E; Todorova I; Politi L; Trifonova A; Borisova M; Kioseva E; Tsakris A
    Chemotherapy; 2017; 62(6):339-342. PubMed ID: 28738348
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Colistin resistance in Klebsiella pneumoniae.
    Ah YM; Kim AJ; Lee JY
    Int J Antimicrob Agents; 2014 Jul; 44(1):8-15. PubMed ID: 24794735
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Lipopolysaccharide O-antigen promotes persistent murine bacteremia.
    Lugo JZ; Price S; Miller JE; Ben-David I; Merrill V; Mancuso P; Weinberg JB; Younger JG
    Shock; 2007 Feb; 27(2):186-91. PubMed ID: 17224794
    [TBL] [Abstract][Full Text] [Related]  

  • 86. In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae.
    Poudyal A; Howden BP; Bell JM; Gao W; Owen RJ; Turnidge JD; Nation RL; Li J
    J Antimicrob Chemother; 2008 Dec; 62(6):1311-8. PubMed ID: 18922815
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Therapeutic Efficacy of Bacteriophage Therapy to Treat Carbapenem Resistant Klebsiella Pneumoniae in Mouse Model.
    Dhungana G; Regmi M; Paudel P; Parajuli A; Upadhyay E; Gyawali I; Upreti H; Nepal R; Pradhan P; Malla R
    J Nepal Health Res Counc; 2021 Apr; 19(1):76-82. PubMed ID: 33934137
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Genomic analysis of a pan-resistant Klebsiella pneumoniae sequence type 11 identified in Japan in 2016.
    Nishida S; Ono Y
    Int J Antimicrob Agents; 2020 Apr; 55(4):105854. PubMed ID: 31770626
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Broad-range capsule-dependent lytic
    Concha-Eloko R; Barberán-Martínez P; Sanjuán R; Domingo-Calap P
    Microbiol Spectr; 2023 Dec; 11(6):e0429822. PubMed ID: 37882584
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A 4.5-Year Within-Patient Evolution of a Colistin-Resistant Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Sequence Type 258.
    Jousset AB; Bonnin RA; Rosinski-Chupin I; Girlich D; Cuzon G; Cabanel N; Frech H; Farfour E; Dortet L; Glaser P; Naas T
    Clin Infect Dis; 2018 Oct; 67(9):1388-1394. PubMed ID: 29688339
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Characterization of ST258 Colistin-Resistant, blaKPC-Producing Klebsiella pneumoniae in a Greek Hospital.
    Mavroidi A; Katsiari M; Likousi S; Palla E; Roussou Z; Nikolaou C; Maguina A; Platsouka ED
    Microb Drug Resist; 2016 Jul; 22(5):392-8. PubMed ID: 26840950
    [TBL] [Abstract][Full Text] [Related]  

  • 92. φBO1E, a newly discovered lytic bacteriophage targeting carbapenemase-producing Klebsiella pneumoniae of the pandemic Clonal Group 258 clade II lineage.
    D'Andrea MM; Marmo P; Henrici De Angelis L; Palmieri M; Ciacci N; Di Lallo G; Demattè E; Vannuccini E; Lupetti P; Rossolini GM; Thaller MC
    Sci Rep; 2017 Jun; 7(1):2614. PubMed ID: 28572684
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Epidemiology and molecular characterisation of colistin-resistant Klebsiella pneumoniae isolates from immunocompromised patients in Tunisia.
    Tanfous FB; Raddaoui A; Chebbi Y; Achour W
    Int J Antimicrob Agents; 2018 Dec; 52(6):861-865. PubMed ID: 30176353
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Insertion sequence transpositions and point mutations in mgrB causing colistin resistance in a clinical strain of carbapenem-resistant Klebsiella pneumoniae from Vietnam.
    Berglund B; Hoang NTB; Tärnberg M; Le NK; Svartström O; Khu DTK; Nilsson M; Le HT; Welander J; Olson L; Larsson M; Nilsson LE; Hanberger H
    Int J Antimicrob Agents; 2018 May; 51(5):789-793. PubMed ID: 29180281
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin.
    Kontopoulou K; Protonotariou E; Vasilakos K; Kriti M; Koteli A; Antoniadou E; Sofianou D
    J Hosp Infect; 2010 Sep; 76(1):70-3. PubMed ID: 20705205
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Genomic Insights into Colistin-Resistant Klebsiella pneumoniae from a Tunisian Teaching Hospital.
    Jaidane N; Bonnin RA; Mansour W; Girlich D; Creton E; Cotellon G; Chaouch C; Boujaafar N; Bouallegue O; Naas T
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229634
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Capsular polysaccharide is a major complement resistance factor in lipopolysaccharide O side chain-deficient Klebsiella pneumoniae clinical isolates.
    Alvarez D; Merino S; Tomás JM; Benedí VJ; Albertí S
    Infect Immun; 2000 Feb; 68(2):953-5. PubMed ID: 10639470
    [TBL] [Abstract][Full Text] [Related]  

  • 98. blaOXA-48 carrying clonal colistin resistant-carbapenem resistant Klebsiella pneumoniae in neonate intensive care unit, India.
    Singh SK; Gupta M
    Microb Pathog; 2016 Nov; 100():75-77. PubMed ID: 27622347
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The emergence of colistin-resistant Klebsiella pneumoniae strains from swine in Malaysia.
    Mobasseri G; Teh CSJ; Ooi PT; Thong KL
    J Glob Antimicrob Resist; 2019 Jun; 17():227-232. PubMed ID: 30611928
    [TBL] [Abstract][Full Text] [Related]  

  • 100. mcr-1 Gene Has No Effect on Colistin Resistance When It Coexists with Inactivated mgrB Gene in Klebsiella pneumoniae.
    Zhang H; Zhao D; Shi Q; Quan J; Li X; Yu Y
    Microb Drug Resist; 2018 Oct; 24(8):1117-1120. PubMed ID: 29768099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.